Prevalence and risk of viral infection in patients with acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis

Molecular Biology Reports

Volumn 41, Issue 7, 2014, Pages 4743-4751

  Wu, Xiaodong ^a   Chen, Du ^b   Gu, Xiaoling ^a   Su, Xin ^a   Song, Yong ^a   Shi, Yi ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

Author keywords

Acute exacerbation; Chronic obstructive pulmonary disease; Respiratory viruses

Indexed keywords

ACUTE EXACERBATION OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE ASSOCIATION; DISEASE SEVERITY; FORCED EXPIRATORY VOLUME; HEALTH CARE PLANNING; HIGH RISK PATIENT; HUMAN; INFECTION RISK; NONHUMAN; OBSTRUCTIVE AIRWAY DISEASE; PREDICTIVE VALUE; PREVALENCE; QUALITY OF LIFE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHINOVIRUS; RISK ASSESSMENT; SYSTEMATIC REVIEW; VIRAL RESPIRATORY TRACT INFECTION; VIRUS DETECTION; VIRUS PATHOGENESIS; COMPLICATION; DISEASE COURSE; FEMALE; INFLUENZA, HUMAN; MALE; META ANALYSIS; PICORNAVIRIDAE INFECTIONS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; RISK; VIROLOGY;

RHINOVIRUS;

DISEASE PROGRESSION; FEMALE; HUMANS; INFLUENZA, HUMAN; MALE; PICORNAVIRIDAE INFECTIONS; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY TRACT INFECTIONS; RISK;

EID: 84903381407     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-014-3345-9     Document Type: Article

References (36)

1. World Health Organization (2011) The 10 leading causes of death by broad income group, 2008. Fact sheet No. 310
2. Seemungal TA, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA (2000) Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 161:1608-1613 (Pubitemid 30329036)
3. Ramsey SD, Sullivan SD (2003) The burden of illness and economic evaluation for COPD. Eur Respir J Suppl 41:29s-35s (Pubitemid 36648152)
4. Wedzicha JA, Seemungal TA (2007) COPD exacerbations: defining their cause and prevention. Lancet 370:786-796 (Pubitemid 47320802)
5. Sethi S (2011) Molecular diagnosis of respiratory tract infection in acute exacerbations of chronic obstructive pulmonary disease. Clin Infect Dis 52(Suppl 4):S290-S295
6. Mohan A, Chandra S, Agarwal D et al (2010) Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review. Respirology 15:536-542
7. Centre for Reviews and Dissemination (2008) Systematic reviews: CRD's guidance for undertaking reviews in healthcare. Centre for Reviews and Dissemination, York
8. NewcombeRG(1998)Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17:857-872
9. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188 (Pubitemid 17189972)
10. Egger M, Davey SG, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. B Med J 315:629-634 (Pubitemid 27387172)
11. Dimopoulos G, Lerikou M, Tsiodras S et al (2012) Viral epidemiology of acute exacerbations of chronic obstructive pulmonary disease. Pulm Pharmacol Ther 25:12-18
12. Bafadhel M, McKenna S, Terry S et al (2011) Acute exacerbations of chronic obstructive pulmonary disease: identification of biologic clusters and their biomarkers. Am J Respir Crit Care Med 184:662-671
13. Kherad O, Kaiser L, Bridevaux PO et al (2010) Upper-respiratory viral infection, biomarkers, and COPD exacerbations. Chest 138:896-904
14. Almansa R, Sanchez-Garcia M, Herrero A et al (2011) Host response cytokine signatures in viral and nonviral acute exacerbations of chronic obstructive pulmonary disease. J Interferon Cytokine Res 31:409-413
15. Daubin C, Parienti JJ, Vabret A et al (2008) Procalcitonin levels in acute exacerbation of COPD admitted in ICU: a prospective cohort study. BMC Infect Dis 8:145
16. McManus TE, Marley AM, Baxter N et al (2008) Respiratory viral infection in exacerbations of COPD. Respir Med 102:1575-1580
17. Papi A, Bellettato CM, Braccioni F et al (2006) Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med 173:1114-1121 (Pubitemid 43726892)
18. Seemungal T, Harper-Owen R, Bhowmik A et al (2001) Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 164:1618-1623 (Pubitemid 33124148)
19. Rohde G, Wiethege A, Borg I et al (2003) Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: a case-control study. Thorax 58:37-42 (Pubitemid 36135356)
20. De Serres G, Lampron N, La Forge J et al (2009) Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations. J Clin Virol 46:129-133
21. Camargo CA Jr, Ginde AA, Clark S, Cartwright CP, Falsey AR, Niewoehner DE (2008) Viral pathogens in acute exacerbations of chronic obstructive pulmonary disease. Intern Emerg Med 3:355-359
22. Beckham JD, Cadena A, Lin J et al (2005) Respiratory viral infections in patients with chronic, obstructive pulmonary disease. J Infect 50:322-330 (Pubitemid 40533369)
23. Bandi V, Jakubowycz M, Kinyon C et al (2003) Infectious exacerbations of chronic obstructive pulmonary disease associated with respiratory viruses and non-typeable Haemophilus influenzae. FEMS Immunol Med Microbiol 37:69-75 (Pubitemid 36588929)
24. Singh M, Lee SH, Porter P et al (2010) Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 125:1369-1378
25. Cameron RJ, de Wit D, Welsh TN, Ferguson J, Grissell TV, Rye PJ (2006) Virus infection in exacerbations of chronic obstructive pulmonary disease requiring ventilation. Intensive Care Med 32:1022-1029 (Pubitemid 43952717)
26. Hutchinson AF, Ghimire AK, Thompson MA et al (2007) A community-based, time-matched, case-control study of respiratory viruses and exacerbations of COPD. Respir Med 101:2472-2481 (Pubitemid 47618387)
27. Ko FW, Ip M, Chan PK et al (2007) Viral etiology of acute exacerbations of COPD in Hong Kong. Chest 132:900-908
28. Sethi S, Murphy TF (2008) Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 359:2355-2365
29. CosioMG,SaettaM,AgustiA(2009)Immunologic aspects of chronic obstructive pulmonary disease. N Engl J Med 360:2445-2454
30. Goris K, Uhlenbruck S, Schwegmann-Wessels C et al (2009) Differential sensitivity of differentiated epithelial cells to respiratory viruses reveals different viral strategies of host infection. J Virol 83:1962-1968
31. Mallia P, Message SD, Gielen V et al (2011) Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 183:734-742
32. Mallia P, Johnston SL (2006) How viral infections cause exacerbation of airway diseases. Chest 130:1203-1210 (Pubitemid 44583754)
33. Schembri S, Morant S, Winter JH, MacDonald TM (2009) Influenza but not pneumococcal vaccination protects against all-cause mortality in patients with COPD. Thorax 64:567-572
34. Edlmayr J, Niespodziana K, Popow-Kraupp T et al (2011) Antibodies induced with recombinant VP1 from human rhinovirus exhibit cross-neutralisation. Eur Respir J 37:44-52
35. Hurst JR, Donaldson GC, Wilkinson TM, Perera WR, Wedzicha JA (2005) Epidemiological relationships between the common cold and exacerbation frequency in COPD. Eur Respir J 26:846-852 (Pubitemid 41632041)
36. Sethi S, Wrona C, Eschberger K, Lobbins P, Cai X, Murphy TF (2008) Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177:491-497 (Pubitemid 351442187)